why novartis� landmark cancer drug approval is great news for bluebird . http://lm360.us/Cova-grandpa-of-Gurkin-from-So-Paulo?Gulnickgr=82
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .